Literature DB >> 11402342

Partners in transcription: NFAT and AP-1.

F Macián1, C López-Rodríguez, A Rao.   

Abstract

Combinatorial regulation is a powerful mechanism that enables tight control of gene expression, via integration of multiple signaling pathways that induce different transcription factors required for enhanceosome assembly. The four calcium-regulated transcription factors of the NFAT family act synergistically with AP-1 (Fos/Jun) proteins on composite DNA elements which contain adjacent NFAT and AP-1 binding sites, where they form highly stable ternary complexes to regulate the expression of diverse inducible genes. Concomitant induction of NFAT and AP-1 requires concerted activation of two different signaling pathways: calcium/calcineurin, which promotes NFAT dephosphorylation, nuclear translocation and activation; and protein kinase C (PKC)/Ras, which promotes the synthesis, phosphorylation and activation of members of the Fos and Jun families of transcription factors. A fifth member of the NFAT family, NFAT5, controls the cellular response to osmotic stress, by a mechanism that requires dimer formation and is independent of calcineurin or of interaction with AP-1. Pharmacological interference with theNFAT:AP-1 interaction may be useful in selective manipulation of the immune response. Balanced activation of NFAT and AP-1 is known to be required for productive immune responses, but the role of NFAT:AP-1 interactions in other cell types and biological processes remains to be understood.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402342     DOI: 10.1038/sj.onc.1204386

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  246 in total

1.  T-cell antigen receptor signal transduction.

Authors:  Doreen A Cantrell
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

2.  rVista for comparative sequence-based discovery of functional transcription factor binding sites.

Authors:  Gabriela G Loots; Ivan Ovcharenko; Lior Pachter; Inna Dubchak; Edward M Rubin
Journal:  Genome Res       Date:  2002-05       Impact factor: 9.043

3.  Asymmetric recognition of nonconsensus AP-1 sites by Fos-Jun and Jun-Jun influences transcriptional cooperativity with NFAT1.

Authors:  Vladimir Ramirez-Carrozzi; Tom Kerppola
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

4.  The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells.

Authors:  Mark Cannon; Nicola J Philpott; Ethel Cesarman
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 5.  Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.

Authors:  Lie Wang; Yumei Xiong; Rémy Bosselut
Journal:  Semin Immunol       Date:  2010-10       Impact factor: 11.130

6.  Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation.

Authors:  Maximilian Diehn; Ash A Alizadeh; Oliver J Rando; Chih Long Liu; Kryn Stankunas; David Botstein; Gerald R Crabtree; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

7.  RANKing c-Jun in osteoclast development.

Authors:  Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

8.  Upregulation of nuclear factor of activated T-cells by nerve injury contributes to development of neuropathic pain.

Authors:  You-Qing Cai; Shao-Rui Chen; Hui-Lin Pan
Journal:  J Pharmacol Exp Ther       Date:  2013-02-05       Impact factor: 4.030

9.  Involvement of hydrogen peroxide in asbestos-induced NFAT activation.

Authors:  Jingxia Li; Bihui Huang; Xianglin Shi; Vincent Castranova; Val Vallyathan; Chuanshu Huang
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

10.  NFATc is required for TGFbeta-mediated transcriptional regulation of fibronectin.

Authors:  Scott L Cobbs; Jennifer L Gooch
Journal:  Biochem Biophys Res Commun       Date:  2007-08-13       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.